Healthcare Global Enterprises Ltd (HEAC)

BSE


	Symbol		Exchange		Currency
	HEAC		NSE		INR	Real-time
	HEAC		BSE		INR	Delayed

Currency in INR

502.95

-0.40(-0.08%)

Closed29/11

Fair Value

Day's Range

494.45

513.45

52 wk Range

310.10

513.45

HEAC Income Statement

Featured here, the Income Statement (earnings report) for Healthcare Global Enterprises Ltd, showing the company's financial performance from operating and non operating activities such as revenue, expenses and income for the last 4 periods (either quarterly or annually).

Advanced Income Statement

Period Ending:

2015

31/03

2016

31/03

2017

31/03

2018

31/03

2019

31/03

2020

31/03

2021

31/03

2022

31/03

2023

31/03

2024

31/03

Total Revenues

10,956.38

10,134.35

13,977.83

16,944.47

19,121.19

Total Revenues Growth

+11.95%

-7.5%

+37.93%

+21.22%

+12.85%

Cost Of Revenues

4,835.8

4,860.38

6,457.15

7,746.91

8,645.74

Gross Profit

6,120.58

5,273.97

7,520.68

9,197.56

10,475.45

Gross Profit Growth

+6.46%

-13.83%

+42.6%

+22.3%

+13.89%

Gross Profit Margin %

55.86%

52.04%

53.8%

54.28%

54.78%

Other Operating Expenses, Total

5,891.11

5,607.71

6,725.22

7,842.31

8,920.59

	Other Operating Expenses, Total Growth
	R&D Expenses
	Selling General & Admin Expenses
	Other Operating Expenses

aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	+10.05%	-4.81%	+19.93%	+16.61%	+13.75%
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-	-	-	-
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	289.18	189.58	273.86	765.17	623.96
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	4,117.48	3,825.96	4,868.52	5,442.41	6,553.07

Operating Income

229.47

-333.74

795.46

1,355.25

1,554.86

Operating Income Growth

-42.07%

-245.44%

+338.35%

+70.37%

+14.73%

EBIT Margin %

2.09%

-3.29%

5.69%

8%

8.13%

Net Interest Expenses

-1,192.18

-980.57

-715.44

-786.5

-852.36

Net Interest Expenses Growth

-153.93%

+17.75%

+27.04%

-9.93%

-8.37%

Interest Expense, Total

-1,234.59

-1,136.68

-831.05

-904.6

-979.33

Interest And Investment Income

42.41

156.11

115.61

118.1

126.97

Other Non Operating Expenses, Total

-231.9

-38.76

-143.21

-113.21

-72.67

EBT, Excl. Unusual Items

-1,194.61

-1,353.07

-63.19

455.54

629.83

Gain (Loss) On Sale Of Assets

0.12

-0.51

-6.43

-13.22

-17.74

Other Unusual Items, Total

0.13

-804.45

951.6

6.13

63.03

EBT, Incl. Unusual Items

-1,192.64

-2,286.63

877.72

448.8

677.29

EBT, Incl. Unusual Items Growth

-257.35%

-91.73%

+138.38%

-48.87%

+50.91%

EBT, Incl. Unusual Items Margin

-10.89%

-22.56%

6.28%

2.65%

3.54%

Income Tax Expense

61.89

-75.61

488.47

272.5

263.95

Net Income to Company

-1,254.53

-2,211.02

389.25

176.3

413.34

Minority Interest

187.58

276.41

148.08

117.19

68.21

Net Income

-1,066.95

-1,934.61

537.33

293.49

481.55

Net Income Growth

-330.27%

-81.32%

+127.77%

-45.38%

+64.08%

Net Income Margin %

-9.74%

-19.09%

3.84%

1.73%

2.52%

Preferred Dividend and Other Adjustments

-

-

-

-

-

Net Income to Common Excl. Extra Items

-1,066.95

-1,934.61

537.33

293.49

481.55

Basic EPS - Continuing Operations

-12.05

-17.02

4.14

2.11

3.46

Basic EPS - Continuing Operations Growth

-327.17%

-41.28%

+124.34%

-49.06%

+63.88%

Diluted EPS - Continuing Operations

-12.05

-17.02

3.97

2.1

3.43

Diluted EPS - Continuing Operations Growth

-327.19%

-41.27%

+123.32%

-47.1%

+63.33%

Basic Weighted Average Shares Outstanding

88.55

113.65

129.71

139.07

139.24

Diluted Weighted Average Shares Outstanding

88.55

113.65

135.18

139.71

140.41

Dividend Per Share

-

-

-

-

-

Dividend Per Share Growth

-

-

-

-

-

EBITDA

1,209.19

656.22

1,784.13

2,372.42

2,671.3

EBITDA Growth

-0.44%

-45.73%

+171.88%

+32.97%

+12.6%

EBITDA Margin %

11.04%

6.48%

12.76%

14%

13.97%

EBIT